InvestorsHub Logo
Followers 6
Posts 491
Boards Moderated 0
Alias Born 03/16/2017

Re: joe botts post# 97858

Wednesday, 11/17/2021 3:12:10 PM

Wednesday, November 17, 2021 3:12:10 PM

Post# of 118363
Acording to Regen website. February 21, 2018 | SOURCE: PRNewswire | Regen BioPharma, Inc. Program to Determine the 3-D Crystal Structure of NR2F6 Progresses to Next Step
Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) has moved into the second stage of its previously-announced program to determine the three-dimensional structure of NR2F6 - with and without its proprietary small molecule drugs bound to it. The object of this structure-determination program is to shed light on how the small molecules bind to and modulate NR2F6 activity.

Just My 2 Bits The truth is incontrovertible. Malice may attack it,
ignorance may deride it, but in the end, there it is. Do Your Own
DD Do not take my Stock post Opinions as investing advice. Nothing I say is financial advise.